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Summary
We evaluated g-irradiated Listeria monocytogenes as
a killed bacterial vaccine, testing the hypothesis that
irradiation preserves antigenic and adjuvant struc-
tures destroyed by traditional heat or chemical inacti-
vation. Irradiated Listeria monocytogenes (LM), unlike
heat-killed LM, efficiently activated dendritic cells via
Toll-like receptors and induced protective T cell re-
sponses in mice. Like live LM, irradiated LM induced
Toll-like-receptor-independent T cell priming. Cross-
presentation of irradiated listerial antigens to CD8+
T cells involved TAP- and proteasome-dependent
cytosolic antigen processing. These results establish
that killed LM can induce protective T cell responses,
previously thought to require live infection. g-irradia-
tion may be potentially applied to numerous bacterial
vaccine candidates, and irradiated bacteria could
serve as a vaccine platform for recombinant antigens
derived from other pathogens, allergens, or tumors.
Introduction
Inactivation and attenuation of pathogens have been
strategies for vaccine development since the advent of
vaccination (Plotkin, 2005). Most current vaccines work
by eliciting protective antibodies, but successful vac-
cines against intracellular pathogens such as HIV and
Mycobacterium tuberculosis will likely require induction
of both humoral and cellular immunity (Robinson and
Amara, 2005). Live attenuated vaccines induce long-
lived cellular and humoral immunity, but safety concerns
limit their utilization. Inactivation, classically by formalin
killing or heat killing, renders safer vaccines with weaker
immunogenicity, eliciting partially protective humoral
immunity that must be maintained with booster shots.
We recently observed that lethal g-irradiation pre-
served the immunomodulatory properties of probiotic
bacteria in a murine model of inflammatory bowel dis-
ease (Rachmilewitz et al., 2004). On the basis of this
observation, we hypothesized that irradiated bacteria
retain adjuvant and antigenic structures that would
*Correspondence: sdatta@ucsd.educonfer immunogenicity to vaccines inactivated by this
strategy. Inactivation of bacteria with g-irradiation for
use in vaccines was preliminarily investigated over 25
years ago in a murine model of Rickettsia (Eisenberg
and Osterman, 1978, 1979; Jerrells et al., 1983). Vac-
cines using irradiation-attenuated pathogens that retain
ability to infect host cells have been developed: Hel-
minths attenuated by irradiation are in use as veterinary
vaccines (Bain, 1999), and irradiation-attenuated proto-
zoa such as Plasmodium have shown promise in human
studies (Clyde, 1990; Hoffman et al., 2002; Rieckmann,
1990). More recently published work demonstrated suc-
cessful vaccination with genetically attenuated Listeria
monocytogenes (LM) mutants that had been inactivated
with ultraviolet light, but these bacteria also retained
metabolic activity that was thought to be necessary for
immunogenicity (Brockstedt et al., 2005).
For our studies investigating the immunogenicity of
lethally irradiated bacteria, we used LM as a model
organism. LM is a facultative intracellular pathogen that
can cause severe systemic disease in immunocompro-
mised hosts (Posfay-Barbe and Wald, 2004). It has been
well established that heat killing abolishes the ability of
LM to elicit protective immunity in mice (Lauvau et al.,
2001; von Koenig et al., 1982). This makes LM a rigorous
model for testing our hypothesis that lethal irradiation
would preserve bacterial immunogenicity and result in
a superior vaccine in comparison to other methods of
killing the pathogen. Systemic infection of mice with
LM has been an important model for understanding
listeriosis and host responses to other intracellular path-
ogens. Work in this model has shown that sublethal in-
fection with LM elicits immunity that is antibody indepen-
dent, is largely mediated by CD8+ T cells, and requires
bacterial expression of listeriolysin O (LLO) (Dussurget
et al., 2004; Pamer, 2004; Portnoy et al., 2002). LLO
mediates escape of LM from phagosomes into the cyto-
sol, resulting in MHC class I presentation of LM antigens
to CD8+ T cells. In the cytosol, the bacteria replicate and
polymerize cellular actin to translocate into neighboring
cells. Using this murine model of infection, we show that
g-irradiated LM, in contrast to heat-killed LM, induced
a protective T cell response in mice.
Results
Inactivation of Listeria monocytogenes
By titrating the g-irradiation dose, we found that Listeria
monocytogenes (LM) were reliably inactivated with a
minimum of 600 krad given at 1.575 krad/min from a
137Cesium source. We confirmed inactivation of each
batch of irradiated LM (IRL) by incubating 23 109 organ-
isms in tryptic soy broth (TSB) and on tryptic soy agar
(TSA) for 48 hr at 37C without any growth. Furthermore,
we intraperitoneally injected 109 IRL into ten MyD88-
deficient mice, which are extremely sensitive to LM in-
fection (Kursar et al., 2004b; Way et al., 2003), and found
that they had no growth of LM in their spleens and livers
3 days after infection, confirming the IRL were nonviable
(data not shown).
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(A) C57BL/6 mice were unvaccinated, sublethally infected with live LM (104 intraperitoneally [i.p.]) on day 0, or vaccinated with heat-killed (HKL)
or g-irradiated (IRL) LM (109 subcutaneously [s.c.]) on days 0 and 7. Mice were then challenged with 23 106 live LM i.p. on day 28 and observed
for survival (10 mice/group, p < 0.0001 by log-rank test). Data shown are representative of two independent experiments.
(B) Colony-forming units (CFU) in liver and spleen were determined on day 31 after vaccination and challenge as above (6–8 mice/group). Data
shown are representative of greater than ten independent experiments.
(C) CFU were determined in mice vaccinated subcutaneously with the indicated doses of IRL according to the vaccination schedule described
above (6 mice/group). Data shown are representative of two independent experiments.
(D) CFU were determined in mice vaccinated s.c. or i.p. with live LM (104) or IRL (109) according to the schedule described above (6 mice/group,
one independent experiment).
(E) CFU were determined in mice vaccinated with IRL or lyophilized IRL according to the schedule described above (109 bacteria s.c./mouse,
6–8 mice/group). Data shown are representative of three independent experiments. Bars denote mean CFU for each group; # denotes mean sig-
nificantly lower than unvaccinated (p < 0.05).IRL Induce Protective Immunity
To test the ability of irradiated LM to elicit protective im-
munity, we left C57BL/6 mice unvaccinated, infected
mice intraperitoneally with a sublethal dose of 104 live
LM (as an established positive control for development
of immunity) on day 0, or vaccinated mice subcutane-
ously at the tail base on day 0 and day 7 with 109 heat-
killed LM (HKL) or IRL. We challenged the mice intraper-
itoneally with approximately 2 3 106 live LM (four times
the dose required to kill 50% of infected animals) on day
28 and observed the mice for survival or sacrificed them
3 days later to measure colony-forming units (CFU) in
the liver and spleen. Eighty percent of mice vaccinated
with IRL survived, whereas 100% of the unvaccinated
or HKL-vaccinated mice died (Figure 1A). Consistent
with this survival benefit, mice vaccinated with IRL
showed a two-log decrease in bacterial load in the
spleen and liver. As expected, HKL vaccination had no
impact on the number of bacteria in these organs (Fig-
ure 1B). Titration of the IRL vaccine dose to 107 organ-
isms/mouse retained similar levels of protection (Fig-
ure 1C). Vaccination by either the subcutaneous or the
intraperitoneal route induced protection (Figure 1D).
Mice vaccinated subcutaneously with 109 lyophilized
IRL were also protected (Figure 1E), holding implications
for development of a lyophilized vaccine that can bestored and transported without refrigeration. Unless
otherwise noted, all subsequent vaccinations with killed
bacteria were done with 109 organisms by the subcuta-
neous route. Sublethal live infection was done by the
intraperitoneal route as described in the published
literature.
IRL-Induced Immunity Is Dependent on CD4+
and CD8+ T Cells
IRL-induced protection was maintained for 12 weeks
after the last vaccination (Figure 2A), indicating persis-
tence of a memory response. This protective memory
response was still evident when mice were challenged
13 months after vaccination (data not shown). Adoptive
transfer of 53 107 T cells from naive, IRL-vaccinated, or
sublethally infected mice conferred an approximately
one-log reduction in spleen and liver CFU in challenged
naive recipient mice, confirming that protection was me-
diated by T cells (Figure 2B). IRL-induced immunity was
dependent on both CD4+ and CD8+ T cells, given that
antibody-mediated depletion of either T cell subset
1 day prior to challenge abolished protection (Figure 2C).
This contrasted with the largely CD8+ T cell-mediated
protection that is induced by live vaccination and
has been reported previously (Pamer, 2004), and which
we confirmed in a separate experiment (Figure 2D).
Irradiated Listeria Induce Cellular Immunity
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(A) Mice vaccinated as in Figure 1A with IRL were challenged 12 weeks after vaccination, and CFU were determined in spleen and liver. Data
shown are representative of two independent experiments.
(B) Mice were unvaccinated, vaccinated with IRL (109) on days 0 and day 7, or sublethally infected with live LM (104) on day 7. T cells isolated from
the spleens of these mice were transferred into naive recipient mice (53 107 cells/recipient mouse) on day 14. The recipient mice were then chal-
lenged as described in Figure 1A, and CFU in spleens and livers of recipient mice were determined on day 17. Data shown are representative of
three independent experiments.
(C–E) Mice vaccinated with IRL (C), live LM (D), or HKL (E) were depleted of CD4+ or CD8+ cells 1 day prior to challenge on day 28, and spleen and
liver CFU were determined on day 31. Data shown are representative of three independent experiments.
(F) Mice were unvaccinated, vaccinated s.c. with 109 IRL or HKL on days 0 and day 7, or sublethally infected i.p. with 104 live LM on day 7. The
mice were challenged i.p. with 105 live LM on day 21. Splenocytes were harvested on day 24 and restimulated with IRL (109/ml) or LLO91-99 (4 mg/
ml) before staining for intracellular IFNg in CD4+ and CD8+ T cells, respectively. Cells were analyzed by gating on CD4+ or CD8+ T cells, and
percentage of IFNg+ cells within each subset is shown as the mean 6 standard deviation (SD) (2 mice/group). Unrestimulated cells and cells
stained with isotype control antibodies showed background levels of IFNg staining (data not shown). Data shown are representative of two
independent experiments.Depletion of either CD4+ or CD8+ cells in HKL-vacci-
nated mice enhanced protection (Figure 2E), consistent
with previous reports suggesting a role for regulatory
T cell populations in HKL-induced immune responses
(Kursar et al., 2004a; Lauvau et al., 2001; Szalay et al.,
1995). Paralleling the level of protection seen after vacci-
nation, intracellular staining of splenocytes showed in-
duction of interferon (IFN)-g-secreting CD4+ and CD8+
T cells in mice after live infection and IRL vaccination
(Figure 2F, Figure S1 in the Supplemental Data available
online).
IRL Induce Toll-Like-Receptor-Dependent Dendritic-
Cell Maturation
Appropriate maturation of dendritic cells (DCs) by mi-
crobial adjuvants is central to the development of pro-
tective T cell responses. To test whether ability to mature
DCs accounted for the improved immunogenicity of
IRL compared to HKL, we cultured bone-marrow-
derived myeloid DCs overnight with titrated concentra-
tions of IRL or HKL and then measured costimulatory
molecule induction and IL-12 (p40 and p70) secretion.IRL were more potent at inducing DC maturation than
HKL (Figure 3A, Figure S2A). Live LM, incubated with
DCs in the presence of antibiotics to prevent cell toxicity
due to bacterial overgrowth, were more potent than IRL
(Figure 3B, Figure S2B).
To test whether Toll-like receptors (TLRs), which rec-
ognize signature microbial components and are a major
pathway for activation of innate immunity (Takeda et al.,
2003), play a role in maturation of DCs by IRL, DCs defi-
cient in MyD88, an adaptor molecule required for most
TLR-mediated signaling, were incubated overnight
with IRL. MyD88-deficient DCs showed impaired induc-
tion of costimulatory molecules and IL-12, induction that
could be partially overcome with increasing doses of IRL
(Figure 3C). DCs deficient in specific TLR molecules
revealed that IRL-mediated maturation was partially
dependent on TLR2, involved in recognition of various
microbial lipopeptides, but not on TLR9, which recog-
nizes immunostimulatory bacterial DNA (Figure 3C). As
expected, deficiency of TLR4, which recognizes LPS
(not present on gram-positive LM), also had no effect
on DC maturation by IRL (data not shown).
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(A and B) C57BL/6 bone-marrow-derived DCs were cultured overnight with IRL, HKL, or live LM. CD80, CD86, and CD40 induction on CD11c+
cells was determined by flow cytometry and expressed as the mean fluorescence intensity ratio (MFIR = fluorescence of treated cells/fluores-
cence of untreated cells). Induction of IL-12 p40 (solid line) and p70 (dashed line) was determined by ELISA.
(C) Maturation of DCs from indicated TLR- or MyD88-deficient mice was assessed as described above after incubation with IRL. Mean values and
error bars indicating SD calculated from triplicate samples are shown and are representative of three independent experiments.IRL Induce TLR-Independent T Cell Activation
Activation of an adaptive immune response requires
both DC maturation and antigen presentation. To com-
plement the DC maturation studies above, we utilized
ovalbumin-specific transgenic T cells to assess the ef-
fects of IRL on antigen presentation. Compared with
DCs incubated with heat-killed LM expressing ovalbu-
min (HKL-OVA), DCs incubated with IRL-OVA more effi-
ciently presented antigen to transgenic OVA-specific
CD4+ T cells (Figure 4A) and cross-presented antigen
to transgenic OVA-specific CD8+ T cells (Figure 4B), as
measured by carboxyfluorescein diacetate succinimidyl
ester (CFSE) dilution in proliferating T cells. As shown in
Figure 4, CD8+ T cell proliferation was consistently more
robust than CD4+ T cell proliferation. In contrast to the
contribution of MyD88 to IRL-mediated DC activation,
various TLR- or MyD88-deficient DCs incubated with
IRL-OVA showed no defect in their ability to present an-
tigen to OVA-specific CD4+ or CD8+ T cells (Figure 4C).
In a separate experiment, MyD88-deficient DCs that
also lacked functional Trif, which mediates MyD88-inde-
pendent TLR signaling (Hoebe et al., 2003), showed no
defects in T cell activation compared to the level in-
duced by wild-type DCs in the same experiment (Fig-
ure 4D). Of note, exogenous loading of unstimulated
DCs with H-2Kb-restricted OVA peptide (SIINFEKL) has
previously documented the ability of antigen-express-
ing immature DCs with basal levels of costimulatory
molecule expression to stimulate T cells in this experi-
mental system (Datta et al., 2003) (also see Figure 6D).Correlating with these in vitro antigen-presentation
studies, TLR2- and TLR9-deficient mice were fully pro-
tected by vaccination with IRL (Figure 5A). We could
not assess T cell priming directly in MyD88-deficient
mice because of high colony counts and early death af-
ter listerial challenge (data not shown), as a result of
innate-immunity defects that fail to adequately control
infection before T cell recall responses can be recruited
(Kursar et al., 2004b; Way et al., 2003). However, spleno-
cytes from IRL-vaccinated MyD88-deficient mice could
transfer protective immunity to naive wild-type mice as
effectively as splenocytes transferred from vaccinated
wild-type donors (Figure 5B), confirming MyD88-inde-
pendent T cell priming in MyD88-deficient mice. This is
consistent with what has been reported for protection
after live LM infection, after which activation of innate
immunity is MyD88 dependent, but T cell priming is
MyD88 independent (Kursar et al., 2004b; Way et al.,
2003). Taken together with these previous reports, our
data suggest that, like immune responses to live LM,
activation of innate immunity by IRL involves TLR-de-
pendent mechanisms, but T cell priming is largely TLR-
independent.
IRL Immunogenicity Is Not Dependent on Bacterial
Protein Synthesis
Treatment of LM, for 1 hr prior to and during irradiation,
with chloramphenicol or gentamicin (100 mg/ml), antibi-
otics that inhibit bacterial protein synthesis, did not
inhibit the ability of IRL to induce DC costimulatory
Irradiated Listeria Induce Cellular Immunity
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(A and B) After overnight incubation with irradiated (IRL-OVA) or heat-killed (HKL-OVA) OVA-expressing LM, DCs were washed and incubated
with CFSE-labeled (A) OVA-specific OT-II CD4+ or (B) OT-I CD8+ T cells for 3 days. T cell proliferation, indicated by CFSE dilution, was determined
by flow cytometry. The percentage of T cells undergoing at least one cell division is indicated on each graph and is representative of three
independent experiments.
(C) T cell proliferation induced by wild-type or indicated TLR- or MyD88-deficient DCs incubated with IRL-OVA (10:1 IRL:DC ratio) was deter-
mined and is representative of two independent experiments.
(D) T cell proliferation induced by wild-type DCs or DCs deficient in both MyD88 and Trif, after incubation with IRL-OVA (10:1 IRL:DC ratio), was
determined and is representative of two independent experiments.molecules (Figure 6A) and be cross-presented by DCs
to OT-I CD8+ T cells (Figure 6B), making it unlikely that
synthesis of proteins as a result of bacterial stress re-
sponses during irradiation (Foster, 2005) contributed
to the immunogenic properties of IRL. Likewise, expos-
ing LM to 1 hr of heat shock (45C) or osmotic shock
(3.5% NaCl) prior to irradiation did not augment the im-
munogenicity of IRL (Figures 6C and 6D). Heat killing
of LM at 70C prior to or after irradiation destroyed its
immunogenic properties (data not shown). Taken to-
gether, these data suggest that the immunogenicity of
IRL is mainly due to preservation of adjuvant and anti-
genic structures, rather than the de novo synthesis of
immunogenic products that has been described with
bacterial responses to environmental stress (Stewart
and Young, 2004). Consistent with these findings and
verifying the nonviability of the IRL preparations, ampi-
cillin treatment of mice, from 1 day prior to 3 days after
each vaccination, did not inhibit the protective response
induced by IRL (Figure 6E).
IRL Antigens Are Cross-Presented by Cytosolic
Antigen Processing Mechanisms
As shown in Figure 2, IRL vaccination induced both
CD4+ and CD8+ T cell responses. Although the CD8+
T cell response was not sufficient for protection, the
unique ability of this killed vaccine to elicit a CD8+ T cell
response indicated cross-presentation of LM antigenson MHC class I after phagocytosis of IRL. Cross-presen-
tation can involve cytosolic or endosomal antigen pro-
cessing (Ackerman and Cresswell, 2004). We found
that cross-presentation of IRL-OVA to transgenic OT-I
CD8+ T cells by DCs was dependent on TAP (transporter
associated with antigen presentation) and sensitive to
lactacystin (proteasome inhibitor), implicating cytosolic
antigen processing (Figure 7A). Controls with DCs
loaded exogenously with SIINFEKL to bypass cellular
processing confirmed that TAP-deficient and lactacys-
tin-treated DCs were capable of activating CD8+ T cells
(Figure 7A). Chloroquine, an inhibitor of endosomal acid-
ification, had no effect on DC cross-presentation of
IRL-OVA (Figure 7B), suggesting that listerial antigens
escape from the endosomal compartment to the cytosol
before endosomal acidification and maturation occurs.
Inhibition of cross-presentation that is mediated by
CpG-containing immunostimulatory DNA (Datta et al.,
2003), and which requires endosomal acidification,
served as a control for chloroquine efficacy (Figure 7B).
The above studies indicated cytosolic processing of
IRL antigens. As mentioned previously, live LM gains
access to the cytosol by listeriolysin O (LLO)-mediated
escape from the endosome and then initiates cytosolic
actin polymerization. Fluorescent microscopy showed
that, unlike live LM, neither IRL nor HKL induced poly-
merization of cytosolic actin into actin tails (green) or
actin coats (yellow) around bacteria taken up by DCs
Immunity
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pended on LLO activity, we vaccinated C57BL/6 mice
with wild-type or LLO-deficient LM that were live or irra-
diated. Live vaccination confirmed the absolute require-
ment for LLO, but protection by IRL vaccination ap-
peared to be only partially abrogated in the absence of
LLO (Figure 7D). LLO is known to play at least two roles
in listerial infections: (1) it mediates escape of bacteria
from endosome to cytosol, and (2) it is a major antigenic
target of anti-Listeria CTL responses (Vijh and Pamer,
1997). It is difficult to separately assess these dual roles
and ascertain whether diminished protection is due to
loss of this major CTL epitope or due to decreased es-
cape of IRL into the cytosol. In vitro studies showed
LLO-independent antigen presentation of IRL by DCs
to CD8+ T cells that are from L9.6 transgenic mice and
recognize an H-2Kd-restricted peptide derived from
listerial p60 (Figure 7E). This suggests that LLO is not
needed for escape of IRL into the cytosol, but further
studies will be needed to confirm the potentially novel
mechanisms involved.
Discussion
Our studies show that lethally irradiated LM induces
protective CD4+ and CD8+ T cell memory responses
and cross-primes CD8+ T cells by TLR-independent
mechanisms. This establishes that killed LM can induce
protective immunity. LM has previously been thought to
only induce immunity if it actively infects cells and gains
Figure 5. Irradiated Listeria Induce TLR-Independent T Cell Priming
In Vivo
(A) Liver and spleen bacterial CFU were determined, as described in
Figure 1, in wild-type or TLR2- or TLR9-deficient mice vaccinated
with IRL.
(B) C57BL/6 (B6) or Myd882/2 mice were vaccinated with IRL, and
control B6 mice were vaccinated with live LM or left unvaccinated
as described in Figure 1. One week after the last vaccination, sple-
nocytes from each group were pooled, and approximately 1.5 3
108 were adoptively transferred intravenously into each B6 recipient
mice. The recipient mice were immediately challenged with live LM,
and bacterial CFU were determined 3 days later as described above.
Data shown are representative of two independent experiments.
# denotes mean significantly lower than unvaccinated mice, as
described in Figure 1.LLO-mediated access to the cytosol. Indeed, a recent
report documenting protection by a ‘‘killed but metabol-
ically active (KBMA)’’ LM vaccine showed dependence
on preserved metabolic activity and functional LLO
(Brockstedt et al., 2005). The KBMA vaccine also re-
quired genetic deletion of DNA repair enzymes and
chemical treatment of LM strains prior to killing by UV
light, in contrast to the direct g-irradiation of wild-type
LM used in our experiments.
Our data suggest that g-irradiation preserves impor-
tant adjuvant and antigenic properties that allow induc-
tion of immunity by killed bacteria. These properties may
also prevent induction of regulatory T cells that seem to
play a role in inhibiting the immune response after vacci-
nation with HKL. Bacterial protein synthesis was not re-
quired for IRL to gain immunogenicity, making it unlikely
that immunogenic bacterial stress-response proteins,
such as those produced during heat shock, osmotic
shock, or g-irradiation, contribute to IRL immunogenic-
ity. TLR pathways play a major role in recognizing micro-
bial adjuvants and are important for the initial control of
LM by the innate immune system. However, on the basis
of this and previous studies, they do not seem to play
a role in T cell priming by LM. It is possible that other,
non-TLR pattern-recognition receptors such as NOD1,
NOD2, PKR, or RIG-I, which are involved in cytosolic
recognition of viruses and other microbes by myeloid
DCs (Kato et al., 2005; Malmgaard, 2004; Philpott and
Girardin, 2004), may play a role in development of anti-
LM T cell responses. It remains to be seen whether acti-
vation of TLR or other pathways with synthetic adju-
vants can further improve the immune response elicited
by IRL vaccination.
Importantly, IRL induced CD8+ T cell responses. Al-
though certain TLR ligands induce cross-presentation
by DCs (Datta et al., 2003; Schulz et al., 2005), our data
suggest TLR-independent cross-presentation of IRL an-
tigens. Other IRL-derived signals, such as those dis-
cussed above, may recruit endoplasmic reticulum-
associated antigen processing machinery to the vicinity
of IRL-containing phagosomes, similarly to what has
been suggested for cross-presentation of other anti-
gens (Guermonprez et al., 2003; Houde et al., 2003). Fur-
ther clarification of these processes will lead to better
understanding of the host response to LM and other
intracellular organisms, creating opportunities for im-
proved vaccine design.
In our studies, lethal g-irradiation preserved adjuvant
and antigenic properties of bacteria destroyed by other
inactivation methods. The improved immunogenicity of
irradiated vaccines may allow development of other in-
activated vaccines against intracellular pathogens that
require T cell immunity, a goal that has been assumed
to require live attenuated vaccines. T cell responses
could also be generated against recombinant antigens
expressed on irradiated bacteria, similar to what was
shown against ovalbumin in our studies. Furthermore,
the time and resources required to identify antigenic
components for use in subunit vaccines, or to create
and select appropriate genetically attenuated organ-
isms, may be avoided if irradiation of whole organisms
proves to be a safe and immunogenic vaccine strategy.
The availability and rapidity of irradiation would expedite
vaccine production and deployment during epidemic
Irradiated Listeria Induce Cellular Immunity
149Figure 6. Irradiated Listeria Immunogenicity
Does Not Require Bacterial Protein Synthesis
(A–D) LM-OVA were treated 1 hr prior to and
during irradiation with chloramphenicol (CM,
100 mg/ml) or gentamycin (GM, 100 mg/ml).
The ability of the irradiated preparations to
induce (A) DC CD40 expression and (B) OT-I
CD8+ T cell proliferation were determined as
described above. Heat shock (HS) at 45C
or osmotic shock (OS) in 3.5% sodium chlo-
ride was done for 1 hr prior to irradiation of
LM-OVA, and (C) DC CD40 expression and
(D) OT-I CD8+ T cell proliferation were deter-
mined after incubation with the irradiated
preparations. Data are representative of two
independent experiments.
(E) Mice were vaccinated with IRL, as previ-
ously described, in the absence or presence
of ampicillin (+amp, 2 mg/ml in drinking water
from 1 day prior to 3 days after each vaccina-
tion), and bacterial CFU in the spleen and liver
were determined after challenge. Data shown
are from one independent experiment. # de-
notes mean significantly lower than unimmu-
nized mice, as described in Figure 1.outbreaks, bioterrorist attacks, and other biothreats.
Additionally, lyophilized irradiated vaccine preparations
should be relatively inexpensive to produce, store, and
transport without refrigeration, bypassing the currently
required cold-chain (MMWR, 2003) and increasing avail-
ability to resource-poor regions where vaccines are
needed most.
Experimental Procedures
Bacteria
Listeria monocytogenes (LM) strain 10403s was a gift from E. Pamer
(Memorial Sloan-Kettering, New York). LLO (hly)-deficient LM was a
gift from D. Portnoy (University of California, Berkeley, California).
Ovalbumin-expressing LM (LM-OVA) was a gift from H. Shen (Uni-
versity of Pennsylvania, Philadelphia) (Foulds et al., 2002). LM
were cultured from frozen stock in tryptic soy broth (TSB, Fisher
Scientific, Pittsburgh) and plated on tryptic soy agar (TSA, Fisher
Scientific) to determine colony-forming units. For heat killing, cul-
tured LM were washed and resuspended with normal saline at
1010 bacteria/ml and heated at 70C in a water bath for 1 hr. For irra-diation, cultured LM were washed and resuspended with normal sa-
line at 1010 bacteria/ml and exposed to 600 krad of g-irradiation over
380 min with a 137Cesium source. When indicated, irradiation was
done with LM pretreated for 1 hr with chloramphenicol (100 mg/ml),
gentamicin (100 mg/ml), heat shock at 45C, or osmotic shock in
3.5% sodium chloride. Lack of growth of heat-killed and irradiated
LM was confirmed by culturing 2 3 109 bacteria for 48 hr at 37C
in TSB and on TSA. The inactivated bacteria were stored at 4C for
up to 4 weeks, and fresh stocks were prepared before each vaccina-
tion experiment. Lyophilization of IRL was done by placing aliquots
on a speed-vac until they were dry, and sterility of the lyophilized
preparation was confirmed by culturing in TSB and on TSA as de-
scribed above.
Animals
C57BL/6 and BALB/c mice were purchased from Harlan Sprague-
Dawley (Indianapolis, Indiana). TAP1-deficient mice and recombina-
tion activation gene-1 (RAG1)-deficient mice on the C57BL/6 back-
ground were obtained from the Jackson Laboratory (Bar Harbor,
Maine) and then bred at our animal facilities. OT-I (OVA TCR, MHC
I-restricted) mice on the C57BL/6 background, expressing a trans-
genic TCR that recognizes OVA-derived peptide in the context of
MHC I (H-2Kb) (Hogquist et al., 1994), were a gift from M. Bevan
Immunity
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(A and B) The ability of TAP-deficient or wild-type DCs incubated for 2 hr with IRL-OVA in the absence or presence of lactacystin (lact, 100 mM) or
chloroquine (CQ, 100 mM) to induce OT-I CD8+ T cell proliferation was determined as described in Figure 4. T cell proliferation induced by similarly
treated DCs incubated with H-2Kb-restricted OVA peptide (OVA pept, 20 pM) or whole OVA protein (0.1 mg/ml) in the presence of immunostimu-
latory CpG DNA (CpG+OVA) were included as controls. Data shown are representative of three independent experiments.
(C) DCs were incubated for 4 hr with live LM, HKL, or IRL and stained with antibody against LM (red) and phalloidin (green) to detect actin
polymerization. Fluoresence was visualized by microscopy at 4003. Images shown are representative of three independent experiments.
(D) C57BL/6 mice were vaccinated, as described in Figure 1, with wild-type or LLO-deficient LM, and liver and spleen bacterial CFU were
determined. Data shown are representative of three independent experiments. p values were determined by ANOVA as described in the Exper-
imental Procedures; n.s. denotes nonsignificant (p > 0.05).
(E) Proliferation of CFSE-labeled p60-specifc CD8+ T cells from L9.6 transgenic mice was determined after 3 day culture with DCs incubated with
wild-type or LLO2/2 IRL. Data shown are representative of three independent experiments.(University of Washington, Seattle) and were subsequently crossed
onto the C57BL/6-Rag12/2 background and bred at our animal facil-
ities. Male OT-II (OVA TCR, MHC II-restricted) mice on the C57BL/6
background, expressing a transgenic TCR that recognizes OVA-de-
rived peptide in the context of MHC II (I-Ab) (Barnden et al., 1998),
were a gift from W. Heath (Walter and Eliza Hall Institute, Melbourne,
Australia) and were subsequently bred at our animal facilities.
TLR2-, TLR4-, TLR9-, and MyD88-deficient mice were a gift from
S. Akira (Osaka University, Osaka, Japan) and bred onto the
C57BL/6 background at our animal facilities. MyD882/2/TRIFlps2
mice, with a frameshift mutation in Trif (Hoebe et al., 2003), were
a gift from B. Beutler (The Scripps Research Institute, La Jolla, Cal-
ifornia). L9.6 mice on the BALB/c-RAG12/2 background, expressinga transgenic TCR that recognizes the MHC-I (H-2Kd)-restricted pep-
tide derived from p60 expressed by LM (Lauvau et al., 2001), were
a gift from E. Pamer and subsequently bred at our animal facilities.
All animal procedures followed the University of California, San
Diego animal-care guidelines.
Vaccination
Unless otherwise noted, mice were sublethally infected intraperito-
neally with 104 live LM on day 0 or vaccinated subcutaneously at
the tail base with 109 IRL or HKL on day 0 and 7. In some instances,
mice were given ampicillin (2 mg/ml) in their drinking water from
days 21 to +3 and days +6 to +10 to inhibit any possible growth or
activity of vaccine bacteria. Treatment of mice with this regimen of
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151ampicillin before and after infection with live LM resulted in complete
inhibition of bacterial growth in spleens and livers (data not shown)
(Badovinac et al., 2004).
After vaccination, mice were challenged with 2 3 106 live LM (ap-
proximately four times the dose required to kill 50% of infected mice)
intraperitoneally on day 28 unless otherwise specified. In some in-
stances, CD4+ or CD8+ cells were depleted 1 day prior to challenge
by intraperitoneal administraton of 1 mg of CD4 (GK1.5) or CD8
(53.6.72) antibodies (Bio Express, West Lebanon, New Hampshire);
flow cytometry of peripheral blood confirmed >99% depletion of
the appropriate cell subset. Three days after challenge, mice were
sacrificed, and spleens and livers were homogenized and plated at
appropriate dilutions onto TSA to determine colony-forming units
after incubation at 37C overnight. In some instances, mice were
observed for mortality for 10 days after challenge.
Adoptive Transfer
A single-cell suspension of splenocytes was pooled from each
group of naive or vaccinated mice 1 week after the last vaccination.
When indicated, CD90 magnetic beads (Miltenyi Biotec, Auburn,
California) were used to isolate T cells to >95% purity according to
the manufacturer’s instructions. Whole splenocytes (1.5 3 108/re-
cipient) or isolated T cells (5 3 107/recipient) were then transferred
intravenously into naive recipient mice. The mice were then immedi-
ately challenged with live LM as described above and sacrificed
3 days later to obtain splenic and hepatic CFU.
Bone-Marrow-Derived Dendritic Cells
Mouse bone-marrow-derived DCs were cultured essentially as pre-
viously described (Datta et al., 2003; Lutz et al., 1999). In brief, bone
marrow from femurs and tibia of C57BL/6 mice was plated on day
0 into bacterial petri dishes (Fisher Scientific) at 5 3 105 cells/ml in
DC medium, which consisted of RPMI (Irvine Scientific, Irvine, Cali-
fornia) supplemented with 10% heat-inactivated FCS (Life Technol-
ogies, Gaithersburg, Maryland), 2 mM L-glutamine (Cellgro, Natham,
Virginia), 100 U/ml penicillin and 100 mg/ml streptomycin (Pen/Strep;
Cellgro), and 5 ng/ml recombinant murine GM-CSF (BD PharMingen,
La Jolla). On day 3, an equal volume of DC medium was added. The
nonadherent cells were harvested on day 6. Flow cytometry, after
staining with antibodies against the following cell-surface markers
or appropriate isotype controls (BD PharMingen), was conducted
to characterize the cultured cells after stimulation: CD11c (clone
HL3), CD40 (clone 3/23), CD80 (clone 16-10A1), and CD86 (clone
GL1).
In Vitro T Cell Proliferation Assay
T cell proliferation was assessed by CFSE dilution with the previ-
ously described DECOT assay (Datta et al., 2003). In brief, bone-
marrow-derived C57BL/6 DCs were incubated overnight with
LM-OVA, OVA (Worthington Biochemicals, Lakewood, New Jersey),
H-2-Kb-restricted OVA peptide (SIINFEKL, PeptidoGenic Research),
or single-stranded phosphorothioate oligonucleotides containing
CpG motifs (50-TGACTGTGAACGTTCGAGATGA-30; Tri-Link Bio-
technology, San Diego, California). When inhibitors were used, the
inhibitors (lactacystin, chloroquine; Sigma-Aldrich, St. Louis, Mis-
souri) were added to the cells 15 min before incubation with the
appropriate stimuli for 2 hr. CD8+ or CD4+ T cells from sex-matched
OT-I or OT-II mice, respectively, were purified from splenocytes
by using anti-CD8 or anti-CD4 magnetic beads (Miltenyi Biotec) ac-
cording to the manufacturer’s instructions. The purified T cells were
stained in PBS containing 1 mM CFSE (Molecular Probes, Eugene,
Oregon). The nonadherent DCs were then washed and incubated
with an equal number of the CFSE-labeled T cells in supplemented
RPMI for 3 days. Flow cytometry was then done on the gated
CD4+ or CD8+ T cell population to assess T cell proliferation, re-
flected by halving of CFSE fluorescence intensity in daughter cells
produced with each round of proliferation. Similar experiments
were also done by using CFSE-labeled CD8+ T cells from L9.6 trans-
genic mice incubated with BALB/c-derived DCs.
Intracellular Cytokine Staining
Naive or vaccinated mice were intraperitoneally challenged with 105
live LM 2 weeks after the last vaccination. Three days after chal-
lenge, splenocytes were harvested and incubated for 6 hr in theabsence or presence of whole IRL (109/ml) or LLO91-99 (GYKDGNEYI,
PeptidoGenic Research, Livermore, California). GolgiStop was
added during the last 4 hr of incubation, and then cells were stained
for CD4, CD8, intracellular IFNg, or appropriate isotype controls
according to the manufacturer’s instructions (BD PharMingen).
Flow Cytometry
All flow-cytometry data were acquired on a FACSCalibur flow cy-
tometer with CellQuest software (BD Biosciences, Franklin Lakes,
New Jersey) after staining of cells with the indicated antibodies in
PBS containing 0.5% BSA and 0.05% sodium azide according to
standard protocols. Data were analyzed with FlowJo software
(Treestar, San Carlos, California).
Fluorescent Microscopy
After staining with AlexaFluor 488-labeled phalloidin (Molecular
Probes) and anti-LM rabbit polyclonal antibody (Fisher) detected
with rhodamine-labeled antibody against rabbit IgG (Jackson Immu-
noResearch Laboratories, West Grove, Pennsylvania) according to
the manufacturer’s instructions, fluorescent microscopy was per-
formed on bone-marrow-derived DCs incubated with indicated LM
preparations.
Statistics
Log-rank tests on Kaplan-Meier survival curves, and ANOVA with
Bonferoni posttest analysis for comparison of means, were per-
formed with Prism 4 for Macintosh (GraphPad Software, San Diego,
California).
Supplemental Data
Supplemental Data include two figures and are available with this
article online at: http://www.immunity.com/cgi/content/full/25/1/
143/DC1/.
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